SOURCE: Gamma Pharmaceuticals Inc.

October 13, 2009 10:22 ET

Gamma Pharmaceuticals Secures Funding for Order Fulfillment

LAS VEGAS, NV--(Marketwire - October 13, 2009) - Gamma Pharmaceuticals Inc. (the "Company") (PINKSHEETS: GMPM) announced the Company has signed an Agreement for Purchase Order Financing and an Account Purchase (Factoring) facility. Combined, the financing package enables Gamma to amplify its manufacturing and retail resources in support of increased demand for the company's products and its substantial purchase order pipeline. Gamma already has in place marketing programs to support sales of the Company's own branded products nationwide. Joseph Cunningham, Gamma's CFO, commented, "We have found a great group to work with and have designed a financing solution that will compress our days outstanding and provide the financial resources to ramp-up our revenue profile." Last week, Gamma announced the signing of an Agreement-in-Principal (the "Agreement") with four-time World Heavyweight Champion, Evander Holyfield. The Agreement outlines a number of commercial opportunities including the development of the "Holyfield Theory" nutritional supplements and training programs as well as cross promotions and marketing support programs for Gamma's own branded products.

About Gamma Pharmaceuticals Inc

Gamma Pharmaceuticals Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in Greater China and the United States. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring the call to action "Mom you've made a brilliant choice for you children's nutrition"; SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy"; and, Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®," to create innovative gel product forms that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact Information